High expression of connective tissue growth factor accelerates dissemination of leukaemia
MetadataShow full item record
To improve treatment of acute lymphoblastic leukaemia (ALL), a better understanding of disease development is needed to tailor new therapies. Connective tissue growth factor (CTGF/CCN2) is highly expressed in leukaemia cells from the majority of paediatric patients with B-lineage ALL (pre-B ALL). CTGF is a matricellular protein and plays a role in aggressive cancers. Here we have genetically engineered leukaemia cells to modulate CTGF expression levels. Elevated CTGF levels accelerated disease dissemination and reduced survival in NOD/SCID mice. In vitro studies showed that CTGF protein induces stromal cell proliferation, promotes adhesion of leukaemia cells to stromal cells and leads to overexpression of genes associated with cell cycle and synthesis of extracellular matrix (ECM). Corresponding data from our leukaemia xenograft models demonstrated that CTGF leads to increased proliferation of non-leukaemia cells and deposition of ECM in the bone marrow. We document for the first time a functional role of CTGF in altering disease progression in a lymphoid malignancy. The findings provide support for targeting the bone marrow microenvironment in aggressive forms of leukaemia.
Showing items related by title, author, creator and subject.
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.Karsa, Mawar; Kosciolek, Angelika; Bongers, Angelika; Mariana, Anna; Failes, Tim; Gifford, Andrew J; Kees, Ursula R; Cheung, Laurence ; Kotecha, Rishi ; Arndt, Greg M; Haber, Michelle; Norris, Murray D; Sutton, Rosemary; Lock, Richard B; Henderson, Michelle J; Somers, Klaartje (2021)BACKGROUND: The prognosis for high-risk childhood acute leukaemias remains dismal and established treatment protocols often cause long-term side effects in survivors. This study aims to identify more effective and safer ...
Kuek, V.; Hughes, A.M.; Kotecha, Rishi ; Cheung, Laurence (2021)In recent decades, the conduct of uniform prospective clinical trials has led to improved remission rates and survival for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia. However, high-risk patients ...
Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia.Foley, Bree; Ta, Clara; Barnes, Samantha; de Jong, Emma; Nguyen, Michelle; Cheung, Laurence ; Buzzai, Anthony; Wagner, Teagan; Wylie, Ben; Fernandez, Sonia; Cruickshank, Mark; Endersby, Raelene; Kees, Ursula; Waithman, Jason (2020)Objectives: Natural killer (NK) cells are an attractive source of cells for an 'off the shelf' cellular therapy because of their innate capacity to target malignant cells, and ability to be transferred between donors and ...